4.17 USD
▼+0.35-0.71%
盘后 4.12 -1.90%
2026-08-03
市值
$241.49M
市盈率
—
EPS
-2.32
股息率
—
52 周区间
2.96 – 40.37
成交量
4.22M
Beta
0.58
目标价
34.40
52W 低 2.9652W 高 40.37
价格走势
公司简介
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The company also develops Exosome protein-based vaccine, which is in preclinical trial to treat SARS-CoV-2; StealthX Exosome Platform, and...